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tal processes in the mouse including the patterning of the
central nervous system and limbs. Reported here for the
first time is the expression of Wnt2 in the early heart field
of 7.5-8.5 dpc (days post-coitum) mouse embryos, making
Wnt2 a potentially useful gene marker for the early stages
of heart development. Expression was also detected in the
allantois from 8.0 dpc and at later stages in the placenta
and umbilicus. Mice deficient in Wnt2, generated by gene
targeting, displayed runting and approximately 50% died
perinatally. Histological analysis revealed alterations in the
size and structure of placentas from these mice from 14.5
dpc. The placental defects were associated primarily with
the labyrinthine zone and included oedema and tissue dis-
ruption and accumulation of maternal blood in large pools.
There was also an apparent decrease in the number of
foetal capillaries and an increase in the amount of fibrinoid
material in the Wnt2 mutant placentas. These results
suggest that Wnt2 is required for the proper vascularisa-
tion of the mouse placenta and the placental defects in
Wnt2-deficient mice result in a reduction in birthweight
and perinatal lethality.
Key words: Wnt2, mouse, embryogenesis, allantois, gene targeting,
placental pathology, perinatal death, IUGRINTRODUCTION
Members of the Wnt gene family have been implicated in a
number of developmental processes in the mouse as well as in
a range of other species. The first Wnt gene identified, Wnt1,
was isolated as a candidate oncogene involved in mammary
tumours of mice (van Ooyen and Nusse, 1984). The
Drosophila orthologue of Wnt1 is the segment polarity gene
wingless (wg), a gene known to play a number of important
roles during the development of the Drosophila embryo
(Rijsewijk et al., 1987; Chu-LeGraff et al., 1993; Couso et al.,
1993; Wu et al., 1995; Skaer et al., 1992). Human WNT2 was
identified by chance during a chromosome walk while
searching for the gene defective in cystic fibrosis (Wainwright
et al., 1988). This was followed soon after by the homology
cloning of the mouse Wnt2 (mirp) cDNA (McMahon and
McMahon, 1989). To date at least 20 distinct Wnt genes have
been identified in Drosophila, zebrafish, Xenopus, chick,
mouse and man.
While W n t genes are expressed in a range of sites in the
developing mouse embryo, the most common sites of
expression are the developing limb and/or the developing
central nervous system (Gavin et al., 1990; Parr et al., 1993;
Christiansen et al., 1995) In some cases, the expression
patterns of certain W n t genes coincide, suggesting that there
may be a degree of functional redundancy between genes
with overlapping expression (McMahon and Bradley, 1990;
McMahon et al., 1992). Null mutations have been generatedfor a number of W n t genes and, in all cases, the genes have
been demonstrated to be essential for the correct develop-
ment of the mouse embryo. W n t 1 ‘knockout’ mice have
defects in the cerebellum often with the complete loss of the
midbrain structures and these mice rarely survive birth
(McMahon and Bradley, 1990; Thomas and Capecchi,
1990). W n t 3 A mutants exhibit defects in tail development,
including absence of the caudal somites, a disrupted
notochord and failure of tailbud formation as well as CNS
defects such as incomplete closure and ‘kinking’ of the
neural tube (Takada et al., 1994). In W n t 4 mutant mice, the
kidneys fail to develop normally and as a result these mice
die soon after birth (Stark et al., 1994). Mutation of the
W n t 7 A gene results in a dorsal-to-ventral transformation of
the limbs of these mutant mice with foot pads and other
ventral structures appearing on the dorsal surface of the
limbs (Parr and McMahon, 1995).
Despite the fact that Wnt2 was the second Wnt gene identi-
fied, its function is still poorly understood. Apart from mice
and humans, the only other species from which possible Wnt2
orthologues have been reported are rat (Levay-Young and
Navre, 1992), sea urchin (partial cDNA with a low level of
homology (Sidow, 1992)) and leech for which a Wnt cDNA
fragment was obtained that demonstrated higher homology
with Wnt2 than any of the other Wnt genes (Kostriken and
Weisblat, 1992). There is very little known about the function
of either human or mouse Wnt2. Wnt2, like all Wnt genes, is
expressed in a restricted pattern during mouse embryogenesis
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also been implicated in normal mammary gland differentiation
(Buhler et al., 1993) and has been indirectly implicated in the
formation of mouse mammary tumours in vivo (Roelink et al.,
1992).
In order to gain some understanding of the role played by
Wnt2 in the development of the mouse we have analysed the
embryonic expression of Wnt2 in embryos from 7.5 dpc to 10.5
dpc using whole-mount in situ hybridisation. In addition to
confirming the pattern of Wnt2 expression reported previously
(McMahon and McMahon, 1989), we observed that Wnt2 is
expressed in the precardiac mesoderm from 7.5 dpc and in the
foetal side of the developing placenta from 8.5 dpc until at least
11.5 dpc. The functional role played by Wnt2 during mouse
embryogenesis was addressed by generating mice that possess
a targeted disruption in the Wnt2 gene. This mutation, which
is predicted to result in the absence of any functional WNT2
protein, causes structural defects in the placenta, which in turn
result in runting and perinatal death. 
MATERIALS AND METHODS
Whole-mount in situ hybridisation
Whole-mount hybridisation and subsequent sectioning of embryos
was performed according to the procedure described in Christiansen
et al. (1995). An adaptation of this method was used for the whole-
mount in situs of placentas where the proteinase K treatment was
increased 10-fold to allow efficient probe penetration. The effi-
ciency of probe penetration using this method has been established
using probes that detect cells throughout the depth of the placenta
(D. J. Pennisi unpublished). For the detection of W n t 2 e x p r e s s i o n ,
two W n t 2 probes were subcloned from a near full-length W n t 2
cDNA clone isolated from a C57Bl6/CBA adult mouse lung library.
One probe was from within the coding region and the other from the
3′ untranslated region. Both probes gave the identical staining
pattern and so only the probe that gave the strongest signal was used
in subsequent experiments. W n t 2 sense probes were used as a
negative control and no staining was observed with these probes (not
s h o w n ) .
Digoxigenin in situ hybridisation of placental sections
In situ hybridisation to placental sections were performed as detailed
in Schaeren-Wiemers and Gerfin-Moser (1993). 
Electroporation of ES cells
Electroporation of ES cells was performed essentially according to
the method of Wurst and Joyner (1993). Colonies were picked
between 7 and 10 days after G418 and FIAU selection.
Morula aggregation
Morula aggregation was performed essentially according to the
tetraploid aggregation method of Nagy and Rossant (1993) with the
exception that only one 8-cell diploid embryo was used per aggrega-
tion with a clump of 10-15 ES cells. 8-cell embryos obtained from
superovulated CD1 females were cultured and transferred to host CD1
pseudopregnant females as described in Nagy and Rossant (1993).
PCR genotyping
Two sets of primers were used in PCR genotyping reactions. One set
amplified the DNA from within the neo coding sequence. The other
set of primers amplified the region within exon 2 of the Wnt2 gene
across the site of the neo insertion. Only DNA that does not contain
a neo gene in exon 2 is amplified by these primers. PCR reactionswere performed in accordance with the protocols supplied by the man-
ufacturers of the Taq polymerase used (Boehringer-Mannheim).
Primers employed were: neo primers: 5′-ATCTCCTGTCATCT-
CACCTTGC-3′ and 5′-CAAGCTCTTCAGCAATATCACG-3′.
Wnt2 primers: 5′-GGTGGTACATGAGAGCTACAGG-3′ and 5′-
CTACTTCGGAGGAGGACC-3′. The amplification conditions were
30 cycles at 94°C for 30 seconds, 60°C for 30 seconds and 72°C for
1 minute. 
RT-PCR
3 µg of total or cytoplasmic RNA was incubated with 100 U of
MMLV reverse transcriptase (BRL) in 10 mM Tris pH 8.3, 50 mM
KCl, 5 mM MgCl2, 0.01% Tween-20, 0.01% NP-40 in the presence
of 1 mM dNTPs for 10 minutes at 25°C followed by 1 hour at 42°C.
1/5 of this reaction was heated to 95°C for 5 minutes then PCR
amplified in the same buffer containing 2 µM of each primer and 1.5
U of Taq polymerase. Three separate primer pairs were used, one pair
to amplify within the HPRT cDNA as a control (5 ′-CCTGCTGGAT-
TACATTAAAGCACTG-3′ and 5′-GTCAAGGGCATATCCAA-
CAACAAAC-3′) and two Wnt2 gene-specific primer pairs; exon 1-3
(5′-GGGGTATGAACGTCCCTCTCGGT3′ and 5′-TCCTTGGC-
TACAGGCCCTGGTG-3′) and exon 3-4 (5′-CGGCCTTTGTT-
TACGCCATC-3′ and 5′-TGAATACAGTAGTCTGGAGAA-3′).
The amplification conditions were 35 cycles at 94°C for 30 seconds,
57°C for 45 seconds and 72°C for 1 minute.
Caesarean section and fostering
Caesarean sections were performed on 18.5 dpc pregnant females
essentially according to the method of Nagy and Rossant (1993).
Following dissection of neonates from the uterus and removal of
foetal membranes, the umbilicus was cut and a segment was retained
for genotyping. The neonates were then placed under a heat lamp on
a damp tissue and were prodded gently at intervals until they had
begun to breath normally. They were then fostered with a female that
had given birth in the past three days and observed at regular intervals
for the next 10-12 hours. 
Histology
Both embryos and other tissues (eg placenta) were fixed overnight at
4°C in 4% paraformaldehyde in PBS. The tissue/embryo was then
embedded in paraffin and either 7 µm (for tissues) or 10 µm (for
embryos) sections were cut. Haematoxylin and eosin was used to stain
placental sections.
RESULTS
Embryonic expression of Wnt2 by whole-mount in
situ hybridisation 
No W n t 2 expression was detected prior to about 7.5 dpc (pre-
headfold) using whole-mount in situ hybridisation (data not
shown). At 7.5 dpc W n t 2 expression was detected in a faint
crescent-shaped pattern, which corresponds to the region of
the heart primordium (Fig. 1A). At approximately 7.75 dpc
when the headfold has become elevated, the foregut involutes
and the differentiation of the heart precursor cells has begun,
W n t 2 expression had increased and was seen in a crescent sur-
rounding the foregut involution (Fig. 1B). Sectioning of these
embryos showed W n t 2 expression was restricted to the meso-
dermal component of the heart field (Fig. 1D,E). Strongest
expression in these embryos was detected in the lateral arms
of the crescent, the prospective sinus venosus, and was
weaker and more diffuse in the medial part of the crescent.
Expression of W n t 2 in 8.0 dpc embryos continued to be
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At this stage, significant structural rearrangements have
begun to occur at the midline where an anterior protrusion
consists of differentiating myocardial and endocardial cells.
W n t 2 expression was weaker in this region of differentiating
cells and strongest in the lateral arms the crescent. At later
stages of development, W n t 2 expression continued in the
regions posterior to the heart such as the septum transversum
and sinus venosus but was much weaker in the heart proper
(Fig. 2A-C).
Other sites of Wnt2 expression include tissues involved in
foetal maternal communication. At 8.0 dpc, Wnt2 expression
was faintly detected in the allantois (Fig. 1C) and by 8.5 dpc
(around the time that the allantois fuses with the chorion to
form the chorioallantoic plate) the level of expression in this
region increased (Fig. 2A). Wnt2 expression is also detected in
the chorioallantoic plate region once allantoic fusion has
occurred (Fig. 2A). The Wnt2 expression in the placental
region at 9.5 dpc and 10.5 dpc continues to be confined to the
chorioallantoic plate region (Fig. 2B,C). Whole-mount in situ
hybridisation of 11.5 dpc placentas demonstrates that Wnt2 is
also expressed in the foetal blood vessels of the placenta (Fig.
2D,E). No expression was seen in any of the placenta that is
derived from foetal trophoblasts.
Targeted disruption of the Wnt2 gene in ES cells
A targeting vector was constructed to allow disruption of the
Wnt2 gene in ES cells by homologous recombination. The
strategy outlined inFig. 3A utilises a positive/negative replace-
ment targeting construct (Mansour et al., 1988) that contains
approximately 10 kb of Wnt2 genomic sequence including
exons 1-3. Following homologous recombination at the Wnt2
locus, exon 2 is disrupted by 1.8 kb of neomycin phospho -
transferase (neo) gene driven by the phosphoglycerate kinase-
1 (pgk) promoter. The insertion of the pgk promoter and neo
gene in exon 2 introduces at least one in frame stop codon pre-
venting the production of full-length WNT2 protein from the
targeted locus. 
Following electroporation of the linearised targeting vector
into R1 ES cells, G418- and FIAU-resistant ES cell colonies
were screened for homologous recombination by Southern
blotting. The screening strategy involved probing S a cI -
digested genomic ES cell DNA with a 3′ external W n t 2 p r o b e
(probe 1) shown in Fig. 3A. A representative Southern blot
used to screen ES cell colonies is shown in Fig. 3B. Of the
96 ES cell colonies picked and screened, 8 were targeted at
the W n t 2 locus. S a cI digests of genomic DNA from these 8
clones and some of the non-targeted clones were also
screened with an internal probe (probe 2, Fig. 3A) and, in all
cases, the same band pattern was seen as for the external
probe (data not shown) indicating that no random, additional
insertion of the targeting vector had occurred in any of these
ES cell clones.
Generation of Wnt2-deficient mice
Six of the eight targeted ES cell lines were successfully used
to generate chimeric mice using diploid morula aggregation.
3 male and 1 female chimeras (each derived from different
targeted ES cell line) when crossed to CD1 mates transmit-
ted their ES-derived genome to their offspring as determinedby coat colour. W n t 2 heterozygous offspring from these
matings were identified by a PCR genotyping strategy, which
showed complete agreement with that used for Southern
analysis (data not shown). From 21 intercross matings, 194
offspring have been genotyped at weaning (Table 1) and of
these 22 (12 males and 10 females) were W n t 2−/−. There were
no deaths observed either before or after weaning in any of
these litters. The distortion in the segregation of genotypes is
highly significant (P<0.0001) for these intercrosses and is
s i g n i ficant (P=0.03) for the W n t 2+ /− × W n t 2−/− crosses. No
s i g n i ficant (P≥0.1 and P=1) segregation distortion was seen
for litters genotyped prior to birth (Table 1) indicating that
the W n t 2−/− mice died between birth and when the litter was
first observed 12-24 hours after birth. Given that the number
of W n t 2−/− expected according to Mendelian inheritance
should be the same as the number of wild-type animals (59)
in the case of the intercrosses or the same as the number of
W n t 2+ /− animals in the case of the W n t 2+ /− × W n t 2−/− c r o s s e s ,
the survival rate for the W n t 2−/− animals is approximately
50%. 
As a number of W n t 2−/− animals subsequently survived to
adulthood, we examined the possibility that functional W n t 2
transcripts were being made from the targeted allele. Reverse
transcriptase PCR (RT-PCR) was performed on RNA
extracted from the lungs and hearts of wild-type, W n t 2+ /− a n d
W n t 2−/− adult mice. W n t 2 primer pairs were used to amplify
across two regions of the W n t 2 mRNA and H P R T g e n e
primers were used for each of the RNA samples as positive
controls (Fig. 3C). H P R T control primers amplified bands in
all samples as did the W n t 2 exon 3-4 primer pair. The W n t 2
exon 1-3 primer pair only amplified a 401 bp product corre-
sponding to wild-type W n t 2 transcript from the W n t 2+ / + a n d
W n t 2+ /− tissues and not from either of the W n t 2−/− tissues. A
band of approximately 250 bp was visible in some of the
tracks containing the exon 1-3 amplification reaction.
Southern blotting indicated this was a non-specific amplific a-
tion product not derived from the W n t 2 gene (data not shown).
This results indicates that no wild-type W n t 2 transcript was
present in the tissues from W n t 2−/− animals. The presence of
transcripts containing exon 3 and 4 in W n t 2−/− tissues indicates
either that W n t 2 transcripts are being made that contain the
n e o in exon 2, or that transcription is initiating downstream of
the n e o gene or that exon skipping has removed exon 2 (and
therefore the n e o insertion). In all cases, given the highly
Table 1. Genotype of offspring from Wnt2+/− × Wnt2+/−
and Wnt2+/− × Wnt2−/− matings
Wnt2 genotype
+/+ +/− −/− P
28 days
+/− × +/− mating 59 113 22 <0.0001
+/− × − /− mating 0 61 39 0.03
≤ 18.5 dpc
+/− × +/− matinga 19 55 16 0.1
+/− × − /− mating† 0 18 19 1
*Ages ranging from 9.5-18.5 dpc
†Ages ranging from 14.5-18.5 dpc
P values calculated using χ2 goodness of fit test for actual genotype
segregation versus predicted.
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residues distributed throughout WNT proteins, it is highly
unlikely that such transcripts would produce functional
protein. 
Perinatal death and runting of Wnt2−/− mice 
To observe animals at and soon after birth when it appeared
some lethality was occurring, litters were delivered from their
mothers at 18.5 dpc by Caesarean section. The details of the
genotypes of the 37 animals delivered by Caesarean section
in these experiments are presented in Table 2. Although all
W n t 2−/− neonates survived Caesarean section, they took
longer to settle into a regular breathing pattern than their litter
mates, remaining grey for many minutes. Some after
continual prompting turned pink and began breathing
regularly but two of these when placed with foster mothers
did not appear to suckle, and died soon after. Of 9 W n t 2−/−
mice delivered, only 5 survived the first 24 hours. Although
m u t a n t animals on dissection appeared anatomically normal,
with subsequent histological examination showing no gross
abnormalities, they were often runted (Fig. 4). Animals were
weighed at various ages both before and after birth and Table
3 shows the mean weights of W n t 2−/− animals and controls.Fig. 1. Analysis of Wnt2 expression in 7.5-8.0 dpc embryos. (A-C) Whole
(B) and an 8.0 dpc embryo (C). Arrowheads, precardiac mesoderm; asteri
differentiating cardiac cells. (D,E) Transverse section through 7.75 dpc (D
splanchnic mesoderm; arrow, myocardial cells; A, allantois; H, head.The difference in the average weights of the two groups
becomes apparent at 14.5 dpc but does not become signifi-
cant until 17.5 dpc. At birth the average weight of the W n t 2−/−
mutants was 67% of the average weight of the controls and
at weaning age both the male and female W n t 2 m u t a n t s
weighed 85% of their normal littermates. There was no dif-
ference between the average weights of wild-type animals
and W n t 2 heterozygotes. 
To date 63 Wnt2−/− mice have been observed from birth to
adulthood. None of these outbred mutant homozygote (31 male
or 32 female) animals have exhibited any apparent physiolog-
ical or anatomical defects. The oldest of these, which at writing
are nearly 2 years old, remains apparently healthy and fertile.
All 8 male and 8 female Wnt2−/− mutants tested were fertile
and, in matings to heterozygotes, the phenotype of control and
mutant offspring was indistinguishable to that of animals
produced from intercross matings. Dissections of 2 adult
W n t 2−/− animals have revealed no obvious abnormalities in
terms of gross anatomy, organ size or organ appearance.
Similarly when the Wnt2− mutation was crossed on to 129/Sv
background although a similar level of perinatal lethality
occurred a proportion of homozygous animals survived to
adulthood and appear normal. -mount in situ analysis of a 7.5 dpc embryo (A), a 7.75 dpc embryo
sk, foregut involution; open arrow, allantois; arrow, protrusion of
) and 8.0 dpc (E) Wnt2 whole-mount embryo. Arrowheads,
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During Caesarean sections, it was observed that some of the
Wnt2 mutant placentas exhibited visible haematomas on the
foetal side of term placentas (Fig. 4D). To investigate possible
defects in placentation, the placentas from both Wnt2 mutant
and control mice were collected at various stages throughout
development and were examined histologically. No significant
abnormalities were observed in 12 mutant placentas prior to
14.5 dpc. Between 14.5 dpc and 18.5 dpc, a number of defects
were observed although the severity of pathology observed
varied between mutant placentas. In a pairwise blinded com-
parison to placentas from control siblings, approximately 85%
of 22 mutant placentas showed at least one defect including
oedema and general disruption in the labyrinthine zone, the
presence of abnormally large and/or numerous maternal blood 
 
 
 
Fig. 2. Whole-mount in situ
analysis of Wnt2 expression
in 8.5 dpc (A), 9.5 dpc (B),
10.5 dpc (C) embryos, 11.5
dpc placenta (D). (E) A
section of the placenta
shown in D showing
expression localised to the
blood vessels of the foetal
circulation. The 8.5 dpc
embryo in A is still attached
to the decidua (d) via the
allantois (white arrow).
Arrowhead, heart; white
arrow, allantois/umbilicus;
red arrow, chorioallantoic
plate; d, decidua; t, tail; h,
head. pools and/or a reduction in the size and proportion of the
labyrinthine zone and the chorioallantoic plate region (Fig. 5).
An increase in the incidence of blood pools and a decrease in
the incidence of oedema was observed as the placentas became
successively older (compare Fig. 5B and I). In some of the
more severe cases, there was often an increase in the amount
of acellular material (often containing dead cells), possibly
fibrinoid, in the labyrinthine zone (Fig. 5G,L). There was an
also apparent reduction in the number of foetal capillaries
when compared with control placentas (compare Fig. 4B,C).
There was no evidence of necrosis or apoptosis in any of the
placentas studied. The severity of pathology in the nine 18.5
dpc placentas of mutant animals delivered by Caesarean
sections showed a close correlation with the degree of runting
and length of survival after birth.  
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Fig. 3. Targeting of the Wnt2 locus. (A) Schematic representation of the targeting strategy showing the targeting vector (top). Homologous
recombination between the targeting vector and the Wnt2 genomic DNA (middle) results in a targeted Wnt2 genomic locus (bottom).
(B) Identification of ES cell lines that carry the targeted Wnt2 locus by Southern blot. The ES cell genomic DNA was digested with SacI and
probed with the external probe shown in A. A 9 kb band indicates an untargeted allele while an 8 kb band identifies the targeted allele. (C) RT-
PCR analysis of Wnt2 transcripts from heart and lung of wild-type (Wnt2+/+), Wnt2+/− and Wnt2−/− mice. Schematic representation of processed
Wnt2 RNA showing positions of primers used in RT-PCR. In the case of targeted alleles the 1.8 kb neo gene is inserted in exon 2. (D) RT-PCR
prducts analysed on agarose gels. Top, RT-PCR performed using primers a and b to amplify from exon 1 to exon 3. Middle, RT-PCR
performed using primers c and d to amplify from exon 3 to exon 4. Bottom, RT-PCR performed using HPRT primers as a positive control. h,
heart RNA; lu, lung RNA. Placentas from Wnt2−/− animals have a normal
number and distribution of trophoblasts
To examine the effect of the W n t 2 mutation on the general
organisation of the mouse placenta, we used in situ hybridis-
ation to detect two different populations of placental tro-
phoblasts in both control and mutant placentas. M o u s e
placental lactogen II (mpl II) was used to detect the tro-
phoblast giant cells while clone 4311 hybridises specific a l l y
to spongiotrophoblast cells. Placental sections from various
developmental stages from 10.5 to 16.5 dpc were used and,
while there was no discernible difference in the pattern of
4311 expression between mutant and control placentas at any
stage (Fig. 6A-D and data not shown), there were slight dif-
ferences in the distribution of the mpl II-expressing giant cells.
This was first observable at 14.5 dpc where in mutants
placentas mpl II-positive cells were detected all the way to the
foetal side of the placenta (Fig. 6G,H). In control placentas
however there are very few mpl II-positive cells towards the
foetal side of the placenta and none in the region of the
chorioallantoic plate (Fig. 6E,F). DISCUSSION
Wnt2 in heart and lung development
Wnt2 is expressed in a temporally and spatially restricted
pattern during embryogenesis but, unlike all other Wnt genes
thus far identified, it is not expressed in either the developing
limbs or CNS. Wnt2 has previously been shown to be
expressed in the heart pericardium and regions associated with
foetal-maternal communication (McMahon and McMahon,
1989) and more recently in the lung mesenchyme of 11.5 and
13.5 dpc embryos (Bellusci et al., 1996). Reported here for the
first time is Wnt2 expression in the regions of the embryo asso-
ciated with early heart development. The expression of Wnt2
in precardiac mesoderm makes it a potentially useful marker
for the initial stages of heart development and suggests a
possible role for Wnt2 in this process. Using gene targeting,
Wnt2 knockout mice have been generated that as adults lack
any detectable expression of the wild-type Wnt2 transcript. No
heart defects were observed in the Wnt2 mutant mice at any
stage of development. Hearts of mutant homozygous mice
began beating at the normal time (8.0-8.5 dpc) and appeared
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Table 2. Survival data on animals delivered by Caesarean
section
Wnt2+/+ Wnt2+/− Wnt2−/−
Birth 3 25 9
1 dpp 3 24 5
Difference 0 1(4%) 4(44%)
Table 3. Average body weights of Wnt2−/− and controls
Average body weights(g) +/− s.e.m.
Age Controls† Wnt2−/− P values*
10.5 dpc 0.028±0.002 0.029±0.001 >0.1
14.5 dpc 0.291±0.009 0.278±0.009 >0.1
15.5 dpc 0.443±0.036 0.413±0.020 >0.1
17.5 dpc 1.13±0.03 0.98±0.02 <0.001
C-section(18.5 dpc) 1.48±0.03 1.09±0.05 <0.001
28 day females 18.43±0.67 15.33±0.56 <0.02
28 day males 21.89±078 18.79±0.83 <0.01
*P values were calculated using the Mann-Whitney test.
†Both Wnt2+/− and Wnt2+/+to continue to develop normally. The gross anatomy of the
hearts of adult Wnt2 mutants was indistinguishable from
control littermates. 
In all other W n t knockouts reported to date, there have
been examples of tissues or regions of the embryo that
express the particular W n t gene but remain unaffected by the
null mutation (McMahon and Bradley, 1990; Stark et al.,
1994; Parr and McMahon, 1995; Takada et al., 1994). For
example, in the case of the extensively characterised W n t 1
knockouts, there is an absence of phenotype in the spinal
cord and myelencephalon, both of which express this gene
(McMahon and Bradley, 1990). There is some evidence that
W n t 3A which has an overlapping expression domain to
W n t 1 may functionally compensate for W n t 1 in these regions
(Augustine et al., 1993, 1995). Functional redundancy may
explain the lack of W n t 2 phenotype in the heart and lung,
although there is no other W n t gene known to be expressed
in the embryonic precursors to these organs. While W n t 1 1 i s
expressed in the bulbus cordis/truncus arteriosus (outflo w
tract) of mouse embryos at 8.5-9.5 dpc (Christiansen et al.,
1995) and W n t 5 A and W n t 5 B are both expressed in the adult
heart (Gavin et al., 1990), none of the murine W n t g e n e s
i d e n t i fied to date are expressed in an overlapping pattern
with Wnt2 either in the heart or the lung. It may be that such
genes exist and have not yet been cloned. Alternative possi-
bilities are that either there may be a minor and as yet unde-
tected phenotype in the W n t 2 mutant mice or that neither
W n t 2 or any other W n t gene is required for either heart or
lung development. 
In addition to the embryonic expression, Wnt2 is also known
to be expressed in at least three adult tissues of the mouse, the
heart, lungs and in the developing mammary gland (Wain-
wright et al., 1988; Weber-Hall et al., 1994; McMahon and
McMahon, 1989). While it has been demonstrated that the
adult Wnt2 mutant mice do not express wild-type Wnt2 RNA
in either their lungs or heart, these animals are apparently
healthy indicating that Wnt2 is not required for the normal
function of these organs. Although Wnt2−/− female mice appear
to be able to rear pups normally, it is possible that the mutation
may have effects on certain stages of mammary gland differ-
entiation and this is currently being investigated. 
Wnt2 and placentation
The generation of Wnt2 null mice has demonstrated a role for
this gene in the development of the haemochorial mouse
placenta. When the embryo implants, the maternal decidua and
uterine blood vessels are initially invaded by foetal tro-
phoblasts, which break down the maternal vessels producing
blood sinuses that are surrounded by trophoblast cells. It is
these trophoblasts that come into direct contact with the foetal
capillaries, which develop from the allantois. As the placentadevelops, the foetal vessels and capillaries invade further into
the placenta establishing the labyrinth-like network of foetal
capillaries interspersed with maternal blood sinuses. It is in
these regions where the foetal capillaries and maternal blood
are separated by only a few cell layers that nutrient exchange
occurs (Ellington, 1985; Amoroso, 1952).
Histopathology observed in the Wnt2 mutant placentas
between 14.5 dpc and 18.5 dpc included a reduction in size and
proportion of the labyrinthine zone with tissue disruption pre-
sumably resulting from severe oedema, an increase in the
acellular fibrin deposits in the labyrinthine zone and regions of
abnormal maternal blood accumulation. All these defects can
be attributed to inadequate circulation of either the maternal
and/or the foetal blood. Inefficient establishment of the foetal
capillary network could result in the oedema due to back
pressure or vessel leakage. The later appearance of the
maternal blood pools and the reduction in labyrinthine oedema
during the development of mutant placentas would suggest that
the oedema is replaced by the blood pools. Regions of acellular
material containing dead cells also appear to have been
deposited in spaces caused by the earlier oedema. This
acellular material is possibly fibrin-type fibrinoid which is
derived primarily from a blood clot of either foetal or maternal
blood (Frank et al., 1994). In many cases, there also appears
to be a reduction in size or a disorganisation of the chorioal-
lantoic plate region. This is seen both in the H & E-stained
placental sections and also in the mpl II in situs. Aside from
this, there appears to be no difference in the number or distri-
bution of the trophoblast giant cells or the spongiotrophoblast
cells. 
Wnt2 expression is confined to the allantoic component of
the mouse haemochorial placenta, which is the precursor of
foetal blood vessels and capillaries. As WNT2 is a secreted
factor probably requiring direct cell-cell contact, it is possible
that it is required in mediating the interaction between the
foetal blood vessels and other cells of the placenta. Despite the
fact that Wnt2 expression is detected in the allantois prior to
its fusion with the pre-placenta at 8.5-9.0 dpc and in some of
the subsequently derived foetal vessels, no histopathology is
observed until 14.5 dpc and significant runting is not detected
for a further three days. This suggests WNT2 is not required
in the initial allantoic invasion but is required to mediate or
maintain the interaction between the foetal vessels and the tro-
phoblasts surrounding the maternal blood sinuses. Several
other mouse gene knockouts have been reported recently that
result in placental defects or pathology: HGF/SF (Uehara et al.,
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Fig. 4. Example of runting in Wnt2−/− mice. A wild-type neonate (A)
and a Wnt2−/− neonate (B) that died within 24 hours of birth.
Pathology evident in a Wnt2 mutant term placenta (D) with a normal
term placenta shown for comparison (C). The largest of a number of
haematomas visible on the foetal side of the mutant placenta is
arrowed. 
Fig. 5. Placentas from W n t 2 mutant homozygous (−/−) and W n t 2
heterozygote (+/−) mice. (A,D) Placentas from normal
(heterozygote) 14.5 dpc embryos, D is a higher magnification of
the labyrinthine zone of A. Note the even cellular distribution and
compact organisation of the labyrinthine zone (lz). No differences
in pathology were noted between wild-type and hetrozygous
placentas. (B,C,E-G) Placentas from 14.5 dpc mutant homozygote
embryos. E and F are higher magnifications of the labyrinthine
zone of C and D respectively. The placenta in B is much thinner
than the control and shows evidence of oedema and tissue
disruption in the labyrinthine zone (seen at higher power in E).
The placenta in C has an accumulation of large blood pools. The
walls of these blood pools are disorganised often with regions of
trophoblast cells protruding into the blood mass (arrow in F). The
absence of nucleated blood cells in the blood of these pools
indicates it is of maternal origin. In G a region of acellular fibrin is
visible (white arrow) with a number of giant cells at the periphery
(black arrow). (H,K) Placentas from 18.5 dpc heterozygote
embryos. K is a higher magnification of the labyrinthine zone of
H. The labyrinthine zone (lz) is organised and compact although,
at this age, the labyrinthine zone makes up a larger proportion of
the placenta than at 14.5 dpc. (I,J,L-N) Placentas from 18.5 dpc
mutant homozygote embryos. L and M are higher magnific a t i o n s
of the labyrinthine zone of I and J respectively. The placenta in I
contains a number of abnormally large blood pools and regions of
fibrin deposit (arrow). The region of fibrin is seen at higher power
in L where cells of various types are distributed throughout the
acellular material. The placenta in J has a much reduced
labyrinthine zone due to the occlusion of this region with blood
pools and oedema (M). N shows an example of severe oedema in
the labyrinthine zone of an 18.5 dpc mutant placenta. sz,
spongiotrophoblastic zone; lz, labyrinthine zone; cap,
chorioallantoic plate; u, umbilicus; y, yolk sac. A-C, H-J scale bar
1 mm; D-G, K-N scale bar =100 µm .1995), VCAM1 (Gurtner et al., 1995), α4 Integrins (Yang et
al., 1995), Mash-2 (Guillemot et al., 1994) and LIFR (Ware et
al., 1995). Disruption of VCAM1 and the α4 Integrin genes
results in defects in the fusion of the allantois to the chorionic
plate resulting in death of the embryo due to lack of formation
of the chorioallantoic placenta. In support of a role for Wnt2
in the consolidation of the foetal vessel network, but not in its
initial establishment, such a fusion defect was not been
observed in the Wnt2 null mice. Only disruption of the low
affinity leukemia inhibitory factor receptor (LIFR) shows
pathology similar to Wnt2 mutants. All LIFR mutant animals
die perinatally at various times within the first 24 hours of
delivery and there is some indication that they are smaller than
their normal littermates. It is difficult to correlate the perinatal
lethality with the placental pathology since there are a number
of other potentially lethal defects found in these embryos
(Ware et al., 1995). 
Perinatal death and runting of Wnt2 mutant animals
Approximately half the Wnt2 homozygous mutants born die
perinatally and many have a lower than average body weight.
Since no other gross defects were apparent and there was a
close correlation in the mutants between severity of placental
defect and the degree of runting and viability, it seems likely
that placentation defects are the cause of the these phenotypiceffects. The placental defects are apparent approximately 3
days prior to the time when the runting of the embryos becomes
significant, which supports this cause-effect relationship.
Defective placental structure and function may reduce the birth
weight of Wnt2 mutant mice by impairing nutritional uptake
or by affecting the placenta’s hormonal regulation of foetal
growth retarding the maturation of the embryo. In humans
there is evidence for a link between placental pathology and
low birthweight babies in a clinical outcome of pregnancy
termed intrauterine growth retardation (IUGR) (Redline,
1995). IUGR results in low birthweight for gestational age
babies and is often associated with a number of clinical and
environmental factors such as preeclampsia, hypertension,
maternal vascular disorders, infection and smoking; although,
in many cases, the aetiology of IUGR remains unknown.
Pathology associated with IUGR includes intervillous fibrin,
abnormal placental blood flow (both maternal and foetal),
maternal floor infarction and a reduction in villous surface area
(equivalent to reduced foetal vascularisation) (Redline, 1995).
There is disagreement as to the relationship between some of
these pathologies and IUGR, although a reduction in villous
surface area clearly correlates with IUGR in at least one study
(Boyd and Scott, 1985). While there are certain structural dif-
ferences between the placentas of mice and humans, they
contain essentially the same basic elements (Ramsey, 1975).
The reduction in birthweight of Wnt2 mutant mice could be
attributed to some of the placental defects seen in these mice
(including apparent reduction in vascularisation and an
increase in fibrin) which approximate the human pathologies
3351Wnt2 is required for placenta development
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Fig. 6. In situ hybridisation analysis of the expression of trophoblast markers in 14.5 dpc placentas. A-D were probed with clone 4311. B and D
are higher magnifications of the central regions of A and C respectively. Cells detected by this probe can be seen to be localised almost
exclusively to the spongiotrophoblastic zone. There is no difference in the expression pattern of this marker in mutants (C,D) compared with
heterozygote controls (A,B). E-H were probed with mpl II. F and H are higher magnifications of the central region of E and G respectively.
Again there is no difference in the marker expression in the spongiotrophoblast zone of mutants (G,H) compared with heterozygote controls
(E,F). There is a difference between mutants and controls in the distribution of the mpl II-positive giant cells in the labyrinthine zone with more
of these cells being found towards the foetal side of the placenta (arrow) in the mutant while in the control there are progressively less of the
mpl II-positive cells towards the chorioallantoic plate (cap) and none in the chorioallantoic plate itself.often associated with IUGR. If this is the case the Wnt2 mice
generated in this study may be of value in understanding the
relationship between placental defects and IUGR.
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